Dr Reddy's launches generic testosterone gel in US market

The company's testosterone gel 1.62 per cent, which is a therapeutic equivalent generic version of AndroGel 1.62 per cent of AbbVie Inc, was approved USFDA.

from Industry-Economic Times
Read The Rest:economictimes...